# OnCo record lrk-4189 (drug). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/drugs/lrk-4189/>
  a schema:Drug ;
  onco:kind "drug" ;
  schema:identifier "lrk-4189" ;
  schema:name "LRK-4189"@en ;
  schema:description "LRK-4189 is an experimental targeted protein degrader from Larkspur Biosciences, in phase 1 trials for microsatellite stable colorectal cancer and solid tumours."@en ;
  schema:url <https://onco.cc/drugs/lrk-4189/> ;
  schema:dateModified "2026-11-03"^^xsd:date ;
  schema:citation <https://larkspur.bio/our-science/>, <https://larkspur.bio/news/>, <https://clinicaltrials.gov/api/v2/studies/NCT07498725>, <https://clinicaltrials.gov/search?intr=LRK-4189> ;
  onco:status "phase-1" ;
  onco:tag "pipeline", "ctgov-ingest" ;
  onco:modality "Targeted protein degrader (oral, daily)" ;
  onco:cancers <https://onco.cc/cancers/metastatic-cancer/> ;
  onco:companies <https://onco.cc/companies/larkspur-biosciences/> ;
  onco:trials <https://onco.cc/trials/nct07498725/> .